Skip to main content

Advertisement

Log in

The small molecule CLP257 does not modify activity of the K+–Cl co-transporter KCC2 but does potentiate GABAA receptor activity

  • Correspondence
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: CLP257 does not affect KCC2 function.

References

  1. Moore, Y.E., Kelley, M.R., Brandon, N.J., Deeb, T.Z. & Moss, S.J. Trends Neurosci. 40, 555–571 (2017).

    Article  CAS  Google Scholar 

  2. Gagnon, M. et al. Nat. Med. 19, 1524–1528 (2013).

    Article  CAS  Google Scholar 

  3. Delpire, E. et al. Bioorg. Med. Chem. Lett. 22, 4532–4535 (2012).

    Article  CAS  Google Scholar 

  4. Rouzaire-Dubois, B., Bostel, S. & Dubois, J.M. Neuroscience 88, 307–317 (1999).

    Article  CAS  Google Scholar 

  5. Rowe, S.M. & Verkman, A.S. Cold Spring Harb. Perspect. Med. 3, a009761 (2013).

    Article  Google Scholar 

  6. Williams, J.R., Sharp, J.W., Kumari, V.G., Wilson, M. & Payne, J.A. J. Biol. Chem. 274, 12656–12664 (1999).

    Article  CAS  Google Scholar 

  7. Zhang, D., Gopalakrishnan, S.M., Freiberg, G. & Surowy, C.S. J. Biomol. Screen. 15, 177–184 (2010).

    Article  CAS  Google Scholar 

  8. Payne, J.A. Am. J. Physiol. 273, C1516–C1525 (1997).

    Article  CAS  Google Scholar 

  9. Delpire, E. et al. Proc. Natl. Acad. Sci. USA 106, 5383–5388 (2009).

    Article  CAS  Google Scholar 

  10. Friedel, P. et al. Sci. Signal. 8, ra65 (2015).

    Article  Google Scholar 

  11. Bornhop, D.J. et al. Science 317, 1732–1736 (2007).

    Article  CAS  Google Scholar 

  12. Hamidi, S. & Avoli, M. Neurobiol. Dis. 79, 51–58 (2015).

    Article  CAS  Google Scholar 

  13. Ostroumov, A. et al. Neuron 92, 493–504 (2016).

    Article  CAS  Google Scholar 

  14. Ferando, I., Faas, G.C. & Mody, I. Nat. Neurosci. 19, 1197–1200 (2016).

    Article  CAS  Google Scholar 

  15. Ferrini, F., Lorenzo, L.E., Godin, A.G., Quang, M.L. & De Koninck, Y. Sci. Rep. 7, 3870 (2017).

    Article  Google Scholar 

  16. Friedel, P., Bregestovski, P. & Medina, I. Front. Mol. Neurosci. 6, 7 (2013).

    Article  CAS  Google Scholar 

  17. Deeb, T.Z., Nakamura, Y., Frost, G.D., Davies, P.A. & Moss, S.J. Eur. J. Neurosci. 38, 2453–2467 (2013).

    Article  Google Scholar 

  18. Pellegrino, C. et al. J. Physiol. (Lond.) 589, 2475–2496 (2011).

    Article  CAS  Google Scholar 

  19. Sivakumaran, S. et al. J. Neurosci. 35, 8291–8296 (2015).

    Article  CAS  Google Scholar 

  20. Grimley, J.S. et al. J. Neurosci. 33, 16297–16309 (2013).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank S. Geschwindner for critical comments and discussion on the manuscript. We would like to thank G.J. Augustine (Korea Institute of Science and Technology) for generously providing the SuperClomeleon construct. This work was supported by funding from AstraZeneca, a grant from the Simons Foundation (206026 to S.J.M.), NIH–NINDS grants NS051195, NS056359, NS081735, and NS087662 (S.J.M.), and NIH–NIMH MH097446 (P.A.D.).

Author information

Authors and Affiliations

Authors

Contributions

R.A.C., T.Z.D., I.M., P.A.D., S.Z., J.D., R.J.M., N.J.B., and S.J.M. designed experiments. R.A.C., K.J., L.I.P., H.J.W., L.J.M., D.J.B., I.C., J.G., L.S., and T.Z.D. performed all the experiments and subsequent analysis. P.M.S., M.P.B., D.H.M., N.D., J.H., M.E.D., R.J.M., and Q.W. produced all reagents or oversaw production of reagents. R.A.C., T.Z.D., I.M., N.J.B., and S.J.M. wrote the manuscript.

Corresponding authors

Correspondence to Nicholas J Brandon, Tarek Z Deeb or Stephen J Moss.

Ethics declarations

Competing interests

K.J., L.J.M., P.M.S., M.P.B., D.J.B., N.D., R.J.M., S.Z., Q.W., J.H., M.E.D., J.D., and N.J.B. are or were full-time employees and shareholders of AstraZeneca. S.J.M. serves as a consultant for SAGE therapeutics and AstraZeneca; these relationships are regulated by Tufts University.

Supplementary information

Supplementary Figures and Table

Supplementary Table 1 and Supplementary Figures 1–5 (PDF 1392 kb)

Life Sciences Reporting Summary (PDF 68 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cardarelli, R., Jones, K., Pisella, L. et al. The small molecule CLP257 does not modify activity of the K+–Cl co-transporter KCC2 but does potentiate GABAA receptor activity. Nat Med 23, 1394–1396 (2017). https://doi.org/10.1038/nm.4442

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.4442

  • Springer Nature America, Inc.

This article is cited by

Navigation